Clicky

Atomo Diagnostics Limited(AT1)

Description: Atomo Diagnostics Limited researches, designs, develops, manufactures, and sells medical devices for blood-based rapid testing for professional use and self-testing. The company offers AtomoRapid RDT platforms to suit various blood-based lateral flow test assays and are appropriate for a range of applications, including screening for chronic conditions and detection of infectious diseases. Its rapid test devices are used by healthcare professionals and by consumers to screen for a range of diseases and medical conditions, including HIV infection. Atomo Diagnostics Limited was founded in 2010 and is headquartered in Leichhardt, Australia.


Keywords: Medicine Clinical Medicine Disease Infectious Diseases Medical Device Infection Chronic Condition Consumers HIV/Aids Screening Epidemiology Ortho Clinical Diagnostics

Home Page: atomodiagnostics.com

AT1 Technical Analysis

3-5 George St
Leichhardt, NSW 2040
Australia
Phone: 61 2 9099 4750


Officers

Name Title
Mr. John Michael Kelly Founder, CEO, MD & Director
Mr. William Edward Souter BCom, LLB (Adel), IPAA Chief Financial Officer
Ms. Chandra Sukumar Chief Operating Officer
Mr. Jim P. McMenamy Head of Bus. Devel. & Partnerships of the Americas
Ms. Anna Tucker Head of Bus. Devel. & Partnerships of Europe, Middle East and Africa
Mr. Tharun Kuppanda Company Sec.

Exchange: AU

Country: AU

Currency: Australian Dollar (A$)

Forward PE: 54.9451
Trailing PE: 0
Price-to-Book MRQ: 1.2194
Price-to-Sales TTM: 2.499
IPO Date:
Fiscal Year End: June
Full Time Employees: 0
Back to stocks